MoneyWorks4Me

Dr. Reddy's Laboratories reports marginal rise in Q3 consolidated net profit

24 Jan 2025 Evaluate

Dr. Reddy's Laboratories has reported results for third quarter ended December 31, 2024 (Q3FY25)

The company has reported 78.75% rise in net profit at Rs 849.40 crore for Q3FY25 as compared to Rs 475.20 crore for the same quarter in the previous year. Total income of the company increased by 21.24% at Rs 5250.40 crore for Q3FY25 as compared to Rs 4330.60 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 2.38% rise in its net profit at Rs 1,413.70 crore for the quarter ended December 31, 2024 as compared to Rs 1380.90 crore for the same quarter in the previous year. Total income of the company increased by 14.47% at Rs 8531.40 crore for Q3FY25 as compared to Rs 7453.00 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..